Patent Update Oncologic, Endocrine & Metabolic: Oncologic, Endocrine & Metabolic: Recent advances in the field of matrix metalloproteinase inhibitors

Autor: Paul Beckett, R
Zdroj: Expert Opinion on Therapeutic Patents; December 1996, Vol. 6 Issue: 12 p1305-1315, 11p
Abstrakt: Matrix metalloproteinases (MMPs) are involved in the normal processes of tissue remodelling and repair, but have increasingly been implicated in a range of disease states where they are over-expressed. This review summarises developments in the design and clinical evaluation of synthetic MMP inhibitors since the subject was last covered in this journal in 1995.
Databáze: Supplemental Index